Logo image of GMHS

GAMEHAUS HOLDINGS INC (GMHS) Stock Fundamental Analysis

NASDAQ:GMHS - Nasdaq - KYG3731B1086 - Common Stock - Currency: USD

1.19  -0.01 (-0.83%)

After market: 1.2 +0.01 (+0.84%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GMHS. GMHS was compared to 72 industry peers in the Entertainment industry. While GMHS seems to be doing ok healthwise, there are quite some concerns on its profitability. GMHS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

GMHS had positive earnings in the past year.
GMHS had a negative operating cash flow in the past year.
GMHS Yearly Net Income VS EBIT VS OCF VS FCFGMHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K 1M

1.2 Ratios

With an excellent Return On Assets value of 3.67%, GMHS belongs to the best of the industry, outperforming 81.94% of the companies in the same industry.
GMHS has a Return On Equity of 3.94%. This is in the better half of the industry: GMHS outperforms 77.78% of its industry peers.
Industry RankSector Rank
ROA 3.67%
ROE 3.94%
ROIC N/A
ROA(3y)-4.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GMHS Yearly ROA, ROE, ROICGMHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -50 -100 -150

1.3 Margins

GMHS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GMHS Yearly Profit, Operating, Gross MarginsGMHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

5

2. Health

2.1 Basic Checks

The number of shares outstanding for GMHS has been increased compared to 1 year ago.
GMHS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GMHS Yearly Shares OutstandingGMHS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
GMHS Yearly Total Debt VS Total AssetsGMHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 9.47 indicates that GMHS is not in any danger for bankruptcy at the moment.
The Altman-Z score of GMHS (9.47) is better than 95.83% of its industry peers.
GMHS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.47
ROIC/WACCN/A
WACCN/A
GMHS Yearly LT Debt VS Equity VS FCFGMHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

GMHS has a Current Ratio of 0.07. This is a bad value and indicates that GMHS is not financially healthy enough and could expect problems in meeting its short term obligations.
GMHS has a worse Current ratio (0.07) than 88.89% of its industry peers.
GMHS has a Quick Ratio of 0.07. This is a bad value and indicates that GMHS is not financially healthy enough and could expect problems in meeting its short term obligations.
GMHS's Quick ratio of 0.07 is on the low side compared to the rest of the industry. GMHS is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
GMHS Yearly Current Assets VS Current LiabilitesGMHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100K 200K 300K 400K 500K

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.10, the valuation of GMHS can be described as very cheap.
Based on the Price/Earnings ratio, GMHS is valued cheaper than 97.22% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, GMHS is valued rather cheaply.
Industry RankSector Rank
PE 4.1
Fwd PE N/A
GMHS Price Earnings VS Forward Price EarningsGMHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GMHS Per share dataGMHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GMHS!.
Industry RankSector Rank
Dividend Yield N/A

GAMEHAUS HOLDINGS INC

NASDAQ:GMHS (4/17/2025, 8:25:05 PM)

After market: 1.2 +0.01 (+0.84%)

1.19

-0.01 (-0.83%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.6%
Inst Owner ChangeN/A
Ins Owners32.48%
Ins Owner ChangeN/A
Market Cap63.75M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.1
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.18
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)0.29
EY24.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS1.01
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 9.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8477%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-134.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-134.62%
OCF growth 3YN/A
OCF growth 5YN/A